In a mouse model of cerebral ischemia, P2X7 receptor antagonists attenuate the production of pro-inflammatory factors in the hippocampus and improve memory deficits and animal survival [235], and TLR4 gene mutation blocks the activation and release of pro-inflammatory factors by microglia in AD [236]. The gene discussed is TLR4; the disease is Alzheimer disease.